We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.38 | 0.78% | 49.39 | 49.33 | 49.36 | 1,268 | 14:00:31 |
From May 2019 to May 2024
Biopharmaceutical company InterMune Inc. (ITMN) has drawn takeover bids from suitors including Sanofi S.A. (SAN.FR), Roche Holding AG (RHHBY), GlaxoSmithKline PLC (GSK) and Actelion Ltd. (ALIOY), Bloomberg News reported Wednesday on its website, citing people with knowledge of the matter.
Goldman Sachs Group Inc. (GS) and Centerview Partners LLC are advising California-based InterMune in the process, the people told Bloomberg.
Full story at: www.bloomberg.com/news/2014-08-13/europe-s-biggest-drugmakers-said-to-bid-for-intermune.html
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
